Mupirocin — Active Pharmaceutical Ingredient

Mupirocin is an active pharmaceutical ingredient found in 3 FDA-approved drug products. Forms: OINTMENT. Routes: TOPICAL.

This content is for informational purposes only. Always consult a healthcare professional.

Mupirocin (3 brand names, 1 dosage form, 1 route)

Available dosage forms: OINTMENT.

Routes of administration: TOPICAL.

Brand Names

  • BACTROBAN
  • CENTANY
  • MUPIROCIN

Indications and Usage

Mupirocin Ointment USP, 2% is indicated for the topical treatment of impetigo due to susceptible isolates of Staphylococcus aureus (S. aureus)and Streptococcus pyogenes (S. pyogenes).

Dosage and Administration

For Topical Use Only. Apply a small amount of Mupirocin Ointment USP, 2%, with a cotton swab or gauze pad, to the affected area 3 times daily for up to 10 days. Cover the treated area with gauze dressing if desired. Re-evaluate patients not showing a clinical response within 3 to 5 days. Mupirocin Ointment USP, 2% is not for intranasal, ophthalmic, or other mucosal use [ see Warnings and Precautions (5.2, 5.6)]. Do not apply Mupirocin Ointment USP, 2% concurrently with any other lotions, creams, or ointments [ see Clinical Pharmacology (12.3)].

Contraindications

Mupirocin Ointment USP, 2% is contraindicated in patients with known hypersensitivity to mupirocin or any of the excipients of Mupirocin Ointment USP, 2%.

Adverse Reactions

The following adverse reactions are discussed in more detail in other sections of the labeling: Severe Allergic Reactions [ see Warnings and Precautions (5.1)] Eye Irritation [ see Warnings and Precautions (5.2)] Local Irritation [ see Warnings and Precautions (5.3)] Clostridium difficile-Associated Diarrhea [ see Warnings and Precautions (5.4)]

Mechanism of Action

Mupirocin is an RNA synthetase inhibitor antibacterial [ see Microbiology (12.4)].

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.